Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of zoonotic diseases among animals
3.2.1.2 Growing advancements in veterinary medicines
3.2.1.3 Increasing demand for meat and animal products
3.2.1.4 Growing government initiatives to control animal diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 Rising concerns over antibiotic resistance
3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Livestock animals
5.2.1 Cattle
5.2.2 Poultry
5.2.3 Swine
5.2.4 Other livestock animals
5.3 Companion animals
5.3.1 Dogs
5.3.2 Cats
5.3.3 Other companion animals
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Antibacterial
6.3 Antifungal
6.4 Antivirals
6.5 Antiparasitics
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Parenteral
7.4 Topical
7.5 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Retail pharmacies
8.3 Online pharmacies
8.4 Veterinary hospital pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Aspen Veterinary Resources
10.2 Boehringer Ingelheim International
10.3 Ceva
10.4 Dechra Pharmaceuticals
10.5 Elanco
10.6 Merck & Co
10.7 Norbrook
10.8 Phibro Animal Health
10.9 Vetoquinol S.A.
10.10 Virbac
10.11 Zoetis
